PRLD Insider Trading

Insider Ownership Percentage: 79.54%
Insider Buying (Last 12 Months): $5,005,008.75
Insider Selling (Last 12 Months): $81,273.60

Prelude Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Prelude Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Prelude Therapeutics Share Price & Price History

Current Price: $4.74
Price Change: Price Decrease of -0.03 (-0.63%)
As of 03/28/2024 01:00 AM ET

This chart shows the closing price history over time for PRLD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Prelude Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2023Krishna VaddiCEOBuy1,000$5.01$5,010.001,066,375View SEC Filing Icon  
5/22/2023Orbimed Advisors LlcDirectorBuy869,565$5.75$4,999,998.7510,119,756View SEC Filing Icon  
4/6/2023Jane HuangCMOSell13,280$6.12$81,273.6024,220View SEC Filing Icon  
12/20/2022Krishna VaddiCEOBuy19,188$5.13$98,434.44120,665View SEC Filing Icon  
12/8/2022Laurent ChardonnetCFOBuy10,000$4.76$47,600.0035,873View SEC Filing Icon  
6/1/2022Laurent ChardonnetCFOBuy10,000$4.23$42,300.0024,500View SEC Filing Icon  
12/13/2021Andrew CombsEVPBuy4,000$12.12$48,480.00View SEC Filing Icon  
11/16/2021Deborah MorosiniEVPSell28,751$15.88$456,565.88View SEC Filing Icon  
10/5/2021David J. MauroInsiderSell15,000$30.96$464,400.00View SEC Filing Icon  
9/7/2021David J. MauroInsiderSell15,000$36.69$550,350.00View SEC Filing Icon  
9/2/2021Christopher PierceEVPSell17,000$41.68$708,560.0020,750View SEC Filing Icon  
8/26/2021Peggy ScherleInsiderSell1,700$35.19$59,823.00View SEC Filing Icon  
8/25/2021Brian PiperCFOSell8,333$33.34$277,822.228,333View SEC Filing Icon  
8/5/2021David J. MauroInsiderSell15,000$31.09$466,350.00View SEC Filing Icon  
7/27/2021Peggy ScherleInsiderSell20,000$35.47$709,400.00View SEC Filing Icon  
7/6/2021David J. MauroInsiderSell15,000$27.47$412,050.0015,000View SEC Filing Icon  
6/7/2021David J. MauroInsiderSell15,000$32.44$486,600.0015,000View SEC Filing Icon  
5/25/2021Brian PiperCFOSell8,333$34.27$285,571.918,333View SEC Filing Icon  
5/7/2021Peggy ScherleInsiderSell10,000$40.82$408,200.00View SEC Filing Icon  
5/5/2021David J. MauroInsiderSell15,000$40.14$602,100.0015,000View SEC Filing Icon  
4/29/2021Christopher PierceEVPSell3,295$40.29$132,755.553,667View SEC Filing Icon  
4/19/2021David J. MauroInsiderSell25,000$30.89$772,250.0025,000View SEC Filing Icon  
4/7/2021Christopher PierceEVPSell828$40.08$33,186.244,578View SEC Filing Icon  
4/7/2021Peggy ScherleinsiderSell15,370$39.31$604,194.7015,383View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Prelude Therapeutics (NASDAQ:PRLD)

79.72% of Prelude Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRLD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Prelude Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/11/2024Vanguard Group Inc.1,006,856$4.30M0.0%+3.4%1.833%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC13,607$58K0.0%N/A0.025%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD1,042,737$4.45M0.0%-2.3%1.902%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC30,526$0.13M0.0%+129.2%0.056%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.1,006,856$4.30M0.0%+3.4%1.836%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC16,797$72K0.0%+21.7%0.031%Search for SEC Filing on Google Icon
2/15/2024Prelude Capital Management LLC14,346$61K0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD1,042,737$4.45M0.0%-2.3%1.902%Search for SEC Filing on Google Icon
2/15/2024Bridgeway Capital Management LLC148,749$0.64M0.0%+302.6%0.271%Search for SEC Filing on Google Icon
2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE63,581$0.27M0.0%+106.6%0.116%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC13,100$56K0.0%N/A0.024%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC44,087$0.19M0.0%+34.0%0.080%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.973,606$3.01M0.0%+2.2%1.776%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.143,957$0.45M0.0%+23.6%0.263%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE30,781$95K0.0%N/A0.056%Search for SEC Filing on Google Icon
11/13/2023Northern Trust Corp115,518$0.36M0.0%+41.6%0.211%Search for SEC Filing on Google Icon
11/13/2023Hsbc Holdings PLC23,198$71K0.0%N/A0.042%Search for SEC Filing on Google Icon
11/13/2023FMR LLC5,131,433$15.86M0.0%-13.6%9.359%Search for SEC Filing on Google Icon
11/9/2023Rhumbline Advisers33,815$0.10M0.0%+13.4%0.062%Search for SEC Filing on Google Icon
11/8/2023Charles Schwab Investment Management Inc.123,031$0.38M0.0%+43.4%0.224%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC13,316$42K0.0%+120.0%0.024%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc160,652$0.50M0.0%+100.0%0.293%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC32,907$0.10M0.0%+29.4%0.060%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC6,052$27K0.0%-41.4%0.011%Search for SEC Filing on Google Icon
8/15/2023Woodline Partners LP248,000$1.12M0.0%N/A0.452%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.23,788$0.11M0.0%-51.9%0.043%Search for SEC Filing on Google Icon
8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board78,300$0.35M0.0%-13.2%0.143%Search for SEC Filing on Google Icon
8/14/2023State Street Corp183,809$0.83M0.0%+318.8%0.335%Search for SEC Filing on Google Icon
8/14/2023Nuveen Asset Management LLC13,804$62K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC183,300$0.83M0.0%+32.3%0.334%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.859,121$3.87M0.0%+103.1%1.567%Search for SEC Filing on Google Icon
8/11/2023The Manufacturers Life Insurance Company 70,165$0.32M0.0%+104.6%0.128%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC242,294$1.09M0.0%+66.1%0.442%Search for SEC Filing on Google Icon
8/11/2023JPMorgan Chase & Co.9,339$42K0.0%+569.9%0.017%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp81,595$0.37M0.0%+285.5%0.149%Search for SEC Filing on Google Icon
8/10/2023Mirae Asset Global Investments Co. Ltd.10,087$45K0.0%N/A0.018%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.85,793$0.39M0.0%+36.5%0.157%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc80,326$0.36M0.0%+182.4%0.147%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC6,052$27K0.0%-41.4%0.013%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp30,816$0.14M0.0%N/A0.064%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC25,428$0.11M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/16/2023Susquehanna International Group LLP129,680$0.74M0.0%+39.0%0.270%Search for SEC Filing on Google Icon
5/16/2023Jane Street Group LLC64,470$0.37M0.0%+283.6%0.134%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458%Search for SEC Filing on Google Icon
5/15/2023Cubist Systematic Strategies LLC8,778$50K0.0%N/A0.018%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Securities LLC10,922$62K0.0%N/A0.023%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP50,500$0.29M0.0%-32.9%0.105%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP22,455$0.13M0.0%-56.7%0.047%Search for SEC Filing on Google Icon
5/15/2023Price T Rowe Associates Inc. MD284,362$1.62M0.0%-5.4%0.593%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC138,500$0.79M0.0%+1.5%0.289%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.423,028$2.41M0.0%+7.5%0.882%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE28,186$0.16M0.0%-82.1%0.059%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP22,175$0.13M0.0%N/A0.046%Search for SEC Filing on Google Icon
5/11/2023FMR LLC4,546,678$25.92M0.0%-0.9%9.481%Search for SEC Filing on Google Icon
5/11/2023Citigroup Inc.70,767$0.40M0.0%+17.8%0.148%Search for SEC Filing on Google Icon
5/9/2023Tower Research Capital LLC TRC 13,352$76K0.0%+278.0%0.028%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC10,322$59K0.0%-88.6%0.022%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC11,201$64K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC16,807$0.10M0.0%N/A0.035%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board100,400$0.61M0.0%-8.0%0.210%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC49,736$0.30M0.0%-17.7%0.104%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley89,949$0.54M0.0%-49.4%0.188%Search for SEC Filing on Google Icon
2/15/2023Man Group plc20,994$0.13M0.0%N/A0.044%Search for SEC Filing on Google Icon
2/15/2023Boothbay Fund Management LLC17,623$0.11M0.0%N/A0.037%Search for SEC Filing on Google Icon
2/14/2023Price T Rowe Associates Inc. MD300,677$1.82M0.0%-4.0%0.629%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC28,631$0.17M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP51,898$0.31M0.0%-50.9%0.109%Search for SEC Filing on Google Icon
2/13/2023Charles Schwab Investment Management Inc.63,721$0.39M0.0%+17.9%0.133%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC90,824$0.55M0.0%+1,657.4%0.190%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC136,500$0.82M0.0%-4.8%0.285%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC144,677$0.87M0.0%-5.5%0.302%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP47,801$0.29M0.0%-11.8%0.100%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE157,824$0.95M0.0%-5.8%0.330%Search for SEC Filing on Google Icon
2/10/2023New York Life Investment Management LLC82,000$0.50M0.0%+11.7%0.171%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP12,759$77K0.0%-12.7%0.027%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.60,072$0.36M0.0%+604.1%0.126%Search for SEC Filing on Google Icon
2/7/2023Bleakley Financial Group LLC22,325$0.14M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP109,533$0.72M0.0%-53.5%0.229%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP105,601$0.70M0.0%-52.8%0.221%Search for SEC Filing on Google Icon
11/15/2022UBS Asset Management Americas Inc.2,402,595$15.88M0.0%-0.7%5.023%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD313,165$2.07M0.0%+1.9%0.655%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.459,134$3.03M0.0%-13.3%0.960%Search for SEC Filing on Google Icon
11/15/2022Caxton Associates LP85,992$0.57M0.1%+2.5%0.180%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada4,200$28K0.0%+67.9%0.009%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC12,641$84K0.0%-71.1%0.026%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC143,400$0.95M0.0%-10.6%0.300%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP14,616$97K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/9/2022Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073%Search for SEC Filing on Google Icon
10/25/2022Denali Advisors LLC8,200$54K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.44,295$0.23M0.0%+83.9%0.093%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD307,353$1.60M0.0%-4.8%0.643%Search for SEC Filing on Google Icon
8/16/2022Corton Capital Inc.15,586$81K0.1%+42.8%0.033%Search for SEC Filing on Google Icon
8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035%Search for SEC Filing on Google Icon
8/15/2022State Street Corp43,889$0.23M0.0%-79.1%0.092%Search for SEC Filing on Google Icon
8/15/2022PDT Partners LLC43,731$0.23M0.0%-39.1%0.091%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC39,938$0.21M0.0%N/A0.083%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC90,937$0.48M0.0%+131.3%0.190%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.2,420,527$12.64M0.0%-0.1%5.060%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Prelude Therapeutics logo
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Read More on Prelude Therapeutics

Today's Range

Now: $4.74
Low: $4.72
High: $5.00

50 Day Range

MA: $3.93
Low: $2.68
High: $4.84

52 Week Range

Now: $4.74
Low: $1.66
High: $8.56

Volume

32,074 shs

Average Volume

49,063 shs

Market Capitalization

$260.32 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Prelude Therapeutics?

Prelude Therapeutics' top insider shareholders include:
  1. Orbimed Advisors Llc (Director)
  2. Krishna Vaddi (CEO)
  3. Laurent Chardonnet (CFO)
  4. Jane Huang (CMO)
Learn More about top insider investors at Prelude Therapeutics.

Who are the major institutional investors of Prelude Therapeutics?

Prelude Therapeutics' top institutional investors include:
  1. Boxer Capital LLC — 4.68%
  2. Price T Rowe Associates Inc. MD — 1.90%
  3. Price T Rowe Associates Inc. MD — 1.90%
  4. Vanguard Group Inc. — 1.84%
  5. Vanguard Group Inc. — 1.83%
  6. Bridgeway Capital Management LLC — 0.27%
Learn More about top institutional investors of Prelude Therapeutics stock.

Which major investors are selling Prelude Therapeutics stock?

During the last quarter, PRLD stock was sold by these institutional investors:
  1. Price T Rowe Associates Inc. MD
  2. Price T Rowe Associates Inc. MD
  3. Citadel Advisors LLC

Which major investors are buying Prelude Therapeutics stock?

Within the last quarter, PRLD stock was acquired by institutional investors including:
  1. Bridgeway Capital Management LLC
  2. Boxer Capital LLC
  3. Vanguard Group Inc.
  4. Vanguard Group Inc.
  5. Pale Fire Capital SE
  6. Barclays PLC
  7. Prelude Capital Management LLC
  8. Virtu Financial LLC
In the last year, these company insiders have bought Prelude Therapeutics stock:
  1. Orbimed Advisors Llc (Director)
  2. Krishna Vaddi (CEO)
  3. Laurent Chardonnet (CFO)
Learn More investors buying Prelude Therapeutics stock.